Angioedema

Immunology and Allergy Clinics of North America

Volumn 34, Issue 1, 2014, Pages 23-31

  Bork, Konrad ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Acquired angioedema; Angioedema; Bradykinin; C1 esterase inhibitor; Factor XII gene mutations; Hereditary angioedema; Histamine; Urticaria

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BRADYKININ; CADHERIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HISTAMINE;

ACUTE URTICARIA; ANGIONEUROTIC EDEMA; AQUAGENIC URTICARIA; CELL JUNCTION; CHOLINERGIC URTICARIA; CHRONIC URTICARIA; CLINICAL FEATURE; COLD URTICARIA; CONTACT URTICARIA; DELAYED PRESSURE URTICARIA; DIFFERENTIAL DIAGNOSIS; ENDOTHELIUM CELL; EPISODIC ANGIOEDEMA WITH EOSINOPHILIA; EXERCISE INDUCED ANAPHYLAXIS; FACTITIAL URTICARIA; HEAT CONTACT URTICARIA; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SOLAR URTICARIA; URTICARIA; URTICARIAL VASCULITIS; VIBRATION INDUCED URTICARIA;

ACQUIRED ANGIOEDEMA; ANGIOEDEMA; BRADYKININ; C1 ESTERASE INHIBITOR; FACTOR XII GENE MUTATIONS; HEREDITARY ANGIOEDEMA; HISTAMINE; URTICARIA;

ANGIOEDEMA; DIAGNOSIS, DIFFERENTIAL; HUMANS; URTICARIA;

EID: 84887997368     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2013.09.004     Document Type: Review

References (23)

1. Dejana E., Orsenigo F., Lampugnani M.G. The role of adherens junctions and VE-cadherin in the control of vascular permeability. JCell Sci 2008, 121:2115-2122.
2. Goddard L.M., Iruela-Arispe M.L. Cellular and molecular regulation of vascular permeability. Thromb Haemost 2013, 109:407-415.
3. Quaranta J.H., Rohr A.S., Rachelefsky G.S., et al. The natural history and response to therapy of chronic urticaria and angioedema. Ann Allergy 1989, 62:421-424.
4. Champion R.H., Roberts S.O., Carpenter R.G., et al. Areview of 554 patients. Br J Dermatol 1969, 81:588-597.
5. Sabroe R.A., Seed P.T., Francis D.M., et al. Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. JAm Acad Dermatol 1999, 40:443-450.
6. Kaplan A.P. Clinical practice. Chronic urticaria and angioedema. NEngl J Med 2002, 346:175-179.
7. Juhlin L. Recurrent urticaria: clinical investigation of 330 patients. Br J Dermatol 1981, 104:369-381.
8. Maurer M., Altrichter S., Bieber T., et al. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. JAllergy Clin Immunol 2011, 128:202-209.
9. Gleich G.J., Schroeter A.L., Marcoux J.P., et al. Episodic angioedema associated with eosinophilia. NEngl J Med 1984, 310:1621-1626.
10. Agostoni A., Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore) 1992, 71:206-215.
11. Bork K., Fischer B., Dewald G. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med 2003, 114:294-298.
12. Bork K., Barnstedt S.E., Koch P., et al. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 2000, 356:213-217.
13. Dewald G., Bork K. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun 2006, 343:1286-1289.
14. Bork K., Wulff K., Meinke P., et al. Anovel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor. Clin Immunol 2011, 141:31-35.
15. Bork K. Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor. Allergy Asthma Clin Immunol 2010, 6:15.
16. Zingale L.C., Castelli R., Zanichelli A., et al. Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management. Immunol Allergy Clin North Am 2006, 26:669-690.
17. Alsenz J., Bork K., Loos M. Autoantibody-mediated acquired deficiency of C1 inhibitor. NEngl J Med 1987, 316:1360-1366.
18. Sabroe R.A., Black A.K. Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema. Br J Dermatol 1997, 136:153-158.
19. Byrd J.B., Adam A., Brown N.J. Angiotensin-converting enzyme inhibitor-associated angioedema. Immunol Allergy Clin North Am 2006, 26:725-737.
20. Dean D.E., Schultz D.L., Powers R.H. Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease. JForensic Sci 2001, 46:1239-1243.
21. Frigas E., Park M. Idiopathic recurrent angioedema. Immunol Allergy Clin North Am 2006, 26:739-751.
22. Zingale L.C., Beltrami L., Zanichelli A., et al. Angioedema without urticaria: a large clinical survey. CMAJ 2006, 175:1065-1070.
23. Lawrence C.M., Jorizzo J.L., Kobza-Black A., et al. Cholinergic urticaria with associated angio-oedema. Br J Dermatol 1981, 105:543-550.